European Respiratory Society (ERS) International Congress 2021

Lung function not affected in children, adolescents post-COVID

Roshini Claire Anthony, 20210927160001

COVID-19 does not appear to result in long-term impairment of lung function in children and adolescents, according to two studies presented at ERS 2021.

Mepolizumab benefits held up over time

Elvira Manzano, 20210925000000

Beyond 1 year, the humanized monoclonal antibody mepolizumab maintained real-world efficacy and safety in patients with severe eosinophilic asthma in the REALITI-A cohort study, reports an expert at ERS 2021.

Adding cyclophosphamide to glucocorticoids confers no survival benefit in IPF

Roshini Claire Anthony, 20210924180001

Adding cyclophosphamide to glucocorticoid treatment in patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) was associated with a numerically increased risk of mortality, according to results of the phase III EXAFIP trial.

The air we breathe in the workplace: Is it safe?

Audrey Abella, 20210924100000

What used to be a place that holds a perception of relative safety and minimal health risk to its occupants, the office now appears to be a place that is inching its way towards the other side of the respiratory health spectrum, with office-related occupational asthma on the rise, according to findings from a UK cross-sectional study presented at ERS 2021.

MV130 immunotherapy prevents COPD exacerbations

Elaine Soliven, 20210924000000

Treatment with MV130, a sublingual bacterial immunotherapy, reduces the number of exacerbations in patients with chronic obstructive pulmonary disease (COPD), according to a recent study presented at ERS 2021.

IMT fast-tracks COVID-19 recovery

Elvira Manzano, 20210923000000

Home-based inspiratory muscle training (IMT) – incorporated into COVID-19 rehabilitation programme – speeds up the recovery of patients in a UK study presented at ERS 2021.

Kids with asthma who are obese likely to respond poorly to ICS

Kids with asthma who are obese respond poorly to ICS

Pearl Toh, 20210922141000

Children with asthma are less likely to respond to inhaled corticosteroid (ICS) if they also happen to obese or overweight, suggests a study presented at ERS 2021.

Exercise during pregnancy tied to better lung function in babies

Pearl Toh, 20210921141000

Infants born to mothers who were inactive during pregnancy were more likely to have low lung function compared with those whose mothers were active while pregnant, according to the PreventADALL study presented at ERS 2021.

Inhaled budesonide may be effective for treating early COVID-19 in adults

Audrey Abella, 20210921100000

The administration of inhaled budesonide for the treatment of early COVID-19 in adults reduced the probability of needing urgent medical care and time to recovery, according to findings from the STOIC* trial presented at ERS 2021.

Inhaled colistimethate sodium reduces bronchiectasis exacerbations

Elaine Soliven, 20210921000000

The use of colistimethate sodium (CMS), delivered via the I-neb, reduces pulmonary exacerbations among patients with bronchiectasis and chronic Pseudomonas aeruginosa (P. aeruginosa) infection, according to the PROMIS-1* study presented at ERS 2021.